Bioavailability and pharmacokinetics of the investigational anticancer agent XK469 (NSC 698215) in rats following oral and intravenous administration
β Scribed by Ramesh R. Boinpally; Sen-Lin Zhou; Patricia M. LoRusso; Ralph E. Parchment
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 239 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of SDZ 64412, an antiasthmatic agent, were investigated following intravenous, oral, and inhalation dosing in rats. 14C-SDZ 64-412 was administered intravenously (2.75 mg kg-') and orally (5.5 mg kg-', 110 mg kg-I), whereas nohradiolabeled drug (5.04 mg kg-') was-administered us
## Abstract The pharmacokinetics of LβFMAUS after intravenous and oral administration (20, 50 and 100 mg/kg) to rats, gastrointestinal firstβpass effect of LβFMAUS (50 mg/kg) in rats, __in vitro__ stability of LβFMAUS, blood partition of LβFMAUS between plasma and blood cells of rat blood, and prot